Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Steinbach

Showing results (291-300 of 369) with videos related to

Pageof 37
Sort By:
Neuro-Oncology|May 11, 2026
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR TrialPhilipp Karschnia, Nico Teske, Emilie Le Rhun, et al.
Oncotarget|March 10, 2016
Diagnostic and clinical relevance of the autophago-lysosomal network in human gliomasLukas Jennewein, Michael W Ronellenfitsch, Patrick Antonietti, et al.
Cancer Immunology Research|October 11, 2019
Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGFMariangela Di Tacchio, Jadranka Macas, Jakob Weissenberger, et al.
Neurological Research and Practice|April 3, 2024
Status epilepticus in patients with brain tumors and metastases: A multicenter cohort study of 208 patients and literature reviewJohanna K Rickel, Daria Zeeb, Susanne Knake, et al.
Nature Cancer|July 1, 2026
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trialLukas Bunse, Katharina Lindner, Antje Wick, et al.
American Journal of Medical Genetics|October 26, 2000
9th international workshop on fragile X syndrome and X-linked mental retardationJ P Fryns, M Borghgraef, T W Brown, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2025
Distress screening in patients with high-grade glioma: diagnostic accuracy in relation to a structured clinical interview in a multicenter cluster-randomized controlled trialRobert Kuchen, Susanne Singer, Melanie Schranz, et al.
Nature|March 25, 2021
A vaccine targeting mutant IDH1 in newly diagnosed gliomaMichael Platten, Lukas Bunse, Antje Wick, et al.
Journal of Neuro-Oncology|July 21, 2019
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trialSied Kebir, Christina Schaub, Nina Junold, et al.
Journal of Neuro-Oncology|January 7, 2023
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trialJ Weller, N Schäfer, C Schaub, et al.
Pageof 37

Showing results (291-300 of 369) with videos related to

Sort By:
Pageof 37
Neuro-Oncology|May 11, 2026
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR TrialPhilipp Karschnia, Nico Teske, Emilie Le Rhun, et al.
Oncotarget|March 10, 2016
Diagnostic and clinical relevance of the autophago-lysosomal network in human gliomasLukas Jennewein, Michael W Ronellenfitsch, Patrick Antonietti, et al.
Cancer Immunology Research|October 11, 2019
Tumor Vessel Normalization, Immunostimulatory Reprogramming, and Improved Survival in Glioblastoma with Combined Inhibition of PD-1, Angiopoietin-2, and VEGFMariangela Di Tacchio, Jadranka Macas, Jakob Weissenberger, et al.
Neurological Research and Practice|April 3, 2024
Status epilepticus in patients with brain tumors and metastases: A multicenter cohort study of 208 patients and literature reviewJohanna K Rickel, Daria Zeeb, Susanne Knake, et al.
Nature Cancer|July 1, 2026
IDH1-mutant vaccine in newly diagnosed astrocytoma: final analysis of the multicenter, single-arm, open-label, first-in-human phase 1 NOA16 trialLukas Bunse, Katharina Lindner, Antje Wick, et al.
American Journal of Medical Genetics|October 26, 2000
9th international workshop on fragile X syndrome and X-linked mental retardationJ P Fryns, M Borghgraef, T W Brown, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 31, 2025
Distress screening in patients with high-grade glioma: diagnostic accuracy in relation to a structured clinical interview in a multicenter cluster-randomized controlled trialRobert Kuchen, Susanne Singer, Melanie Schranz, et al.
Nature|March 25, 2021
A vaccine targeting mutant IDH1 in newly diagnosed gliomaMichael Platten, Lukas Bunse, Antje Wick, et al.
Journal of Neuro-Oncology|July 21, 2019
Baseline T1 hyperintense and diffusion-restricted lesions are not linked to prolonged survival in bevacizumab-treated glioblastoma patients of the GLARIUS trialSied Kebir, Christina Schaub, Nina Junold, et al.
Journal of Neuro-Oncology|January 7, 2023
Patterns, predictors and prognostic relevance of high-grade hematotoxicity after temozolomide or temozolomide-lomustine in the CeTeG/NOA-09 trialJ Weller, N Schäfer, C Schaub, et al.
Pageof 37